Interim analysis of AURORA 2 Extension study: 🦋Voclosporin maintained meaningful reductions in UPCR and eGFR remained stable until month 30. 🦋No unexpected new AEs Promising results! @RheumNow #ACR21 #ACRBest abs1425 https://t.co/hBB6k0bDYb